Tuomas Tammela: Co-targeting classical cells and KRAS augments response in pancreas cancer
Tuomas Tammela, Associate Member at Memorial Sloan Kettering Cancer Center, shared on X:
“New Paper! Anupriya Singh and Hannah Styers from the lab find acute resistance to targeting KRAS in pancreas cancer is surprisingly driven by a classical epithelial state.
Co-targeting classical cells and KRAS augments response – clinically important!”
Source: Tuomas Tammela/X
A classical epithelial state drives acute resistance to KRAS inhibition in pancreas
Authors: Anupriya Singhal, Hannah C. Styers, Jonathan Rub, Zhuxuan Li, Stefan R. Torborg, Jung Yun Kim, Olivera Grbovic-Huezo, Huijin Feng, Zeynep Cagla. Tarcan, Hulya Sahin Ozkan, Jill Hallin, Olca Basturk, Rona Yaeger, James G. Christensen, Doron Betel, Yan Yan, Iok In Christine Chio, Elisa de Stanchina, Tuomas Tammela
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023